21.04.2015 - ChemoCentryx, Inc, a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, has begun enrolling patients with non-resectable...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)